Integral Health Asset Management, LLC Cabaletta Bio, Inc. Transaction History
Integral Health Asset Management, LLC
- $1.12 Billion
- Q4 2024
A detailed history of Integral Health Asset Management, LLC transactions in Cabaletta Bio, Inc. stock. As of the latest transaction made, Integral Health Asset Management, LLC holds 500,000 shares of CABA stock, worth $1.1 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
500,000
Previous 450,000
11.11%
Holding current value
$1.1 Million
Previous $2.12 Million
48.21%
% of portfolio
0.1%
Previous 0.25%
Shares
5 transactions
Others Institutions Holding CABA
# of Institutions
115Shares Held
39.6MCall Options Held
297KPut Options Held
98.6K-
Black Rock Inc. New York, NY4.76MShares$10.5 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$8.96 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.63MShares$8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.87MShares$6.31 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.76MShares$6.07 Million1.64% of portfolio
About Cabaletta Bio, Inc.
- Ticker CABA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,014,000
- Market Cap $63.8M
- Description
- Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...